CryoCell International Inc (CCEL)vsThe Ensign Group Inc (ENSG)
CCEL
CryoCell International Inc
$3.10
-0.64%
HEALTHCARE · Cap: $25.13M
ENSG
The Ensign Group Inc
$203.89
+0.48%
HEALTHCARE · Cap: $11.85B
Smart Verdict
WallStSmart Research — data-driven comparison
The Ensign Group Inc generates 15923% more annual revenue ($5.06B vs $31.57M). ENSG leads profitability with a 6.8% profit margin vs -7.7%. CCEL appears more attractively valued with a PEG of 1.34. ENSG earns a higher WallStSmart Score of 57/100 (C).
CCEL
Hold37
out of 100
Grade: F
ENSG
Buy57
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for CCEL.
Margin of Safety
-0.3%
Fair Value
$211.28
Current Price
$203.89
$7.39 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 129 in profit
Revenue surging 20.2% year-over-year
Areas to Watch
Smaller company, higher risk/reward
Revenue declined 2.3%
Earnings declined 30.8%
Currently unprofitable
Expensive relative to growth rate
Premium valuation, high expectations priced in
6.8% margin — thin
Comparative Analysis Report
WallStSmart ResearchBull Case : CCEL
The strongest argument for CCEL centers on Return on Equity. PEG of 1.34 suggests the stock is reasonably priced for its growth.
Bull Case : ENSG
The strongest argument for ENSG centers on Revenue Growth. Revenue growth of 20.2% demonstrates continued momentum.
Bear Case : CCEL
The primary concerns for CCEL are Market Cap, Revenue Growth, EPS Growth.
Bear Case : ENSG
The primary concerns for ENSG are PEG Ratio, P/E Ratio, Profit Margin.
Key Dynamics to Monitor
CCEL profiles as a turnaround stock while ENSG is a growth play — different risk/reward profiles.
ENSG carries more volatility with a beta of 0.80 — expect wider price swings.
ENSG is growing revenue faster at 20.2% — sustainability is the question.
ENSG generates stronger free cash flow (133M), providing more financial flexibility.
Bottom Line
ENSG scores higher overall (57/100 vs 37/100) and 20.2% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
CryoCell International Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Cryo-Cell International, Inc. is dedicated to cell processing and cryogenic cell storage with a focus on collecting and preserving umbilical cord blood stem cells for family use. The company is headquartered in Oldsmar, Florida.
The Ensign Group Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company is headquartered in San Juan Capistrano, California.
Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?